Skip to main content

Table 2 Characteristics of the annual number of visits and the Annual Accumulate Duration of Time spent with a primary care physician during 2012

From: A new marker of primary care utilization - annual accumulated duration of time of visits

  

No. of visits during 2012

AADT during 2012 (in minutes)

Mean (± Range, SD)

 

8.8 (0–136, 9.1)

65.8 (0–1659, 75.8)

Median (± Range, IQR)

 

6 (0–136, 10)

43 (0–1659, 75)

Characteristic

  

Pearson Correlation

P Value

Pearson Correlation

P Value

 Age (in years)

  

0.4

0.000

0.4

0.000

 Charlson comorbidity index

  

0.5

0.000

0.5

0.000

   

Mean (±SD)

T-TEST

P Value

Mean (±SD)  T-TEST

P Value

Gender

Male

 

7.7 (8.9)

<0.001

57.5 (73.8)

<0.05

 

Female

 

9.8 (9.2)

 

73.3 (76.7)

 

Socioeconomic status

Other

 

7.7 (8.0)

<0.001

58.5 (68.3)

<0.05

 

Low SES

 

14.7 (11.9)

 

104.5 (98.4)

 

Country of birth

New immigrant

 

7.7 (8.1)

<0.05

57.1 (67.4)

<0.05

 

Other

 

9.0 (9.2)

 

67.1 (76.8)

 
   

Mean (±SD)

ANOVA

P Value

Mean (±SD)

ANOVA

P Value

Place of residence

Large city

 

8.7 (8.9)

<0.05

66.9 (75.3)

<0.05

 

Other city

 

8.8 (9.0)

 

62.8 (70.0)

 
 

Kibbutz

 

11.9 (11.9)

 

100.3 (116.9)

 
 

Cooperative Israeli settlement

 

8.3 (8.5)

 

67.1 (78.0)

 
 

Small town

 

8.5 (8.8)

 

62.1 (71.9)

 
 

Non-Jewish settlement

 

8.7 (9.5)

 

59.5 (71.3)

 

Chronic Diseases

 

N

Mean (±SD)

T-TEST

P Value

Mean (±SD)

T-TEST

P Value

 Malignancy

+

4250

16.4 (12)

<0.05

123.5 (103.4)

<0.05

 

72,997

8.4 (8.7)

 

62.4 (72.4)

 

 Diabetes

+

9065

17.5 (11.9)

 

124.6 (100.4)

 
 

68,182

7.7 (8)

 

58 (68.1)

 

 Hypertension

+

16,848

15.9 (11.5)

 

115.9 (98.7)

 
 

60,399

6.8 (7.2)

 

51.8 (61)

 

 Hyperlipidemia

+

27,266

13.7 (10.7)

 

100.3 (90.8)

 
 

49,981

6.1 (6.7)

 

47 (58)

 

 IHD

+

5604

18.4 (12.6)

 

132.9 (107.2)

 
 

71,643

8.1 (8.3)

 

60.5 (70.1)

 

 CHF

+

985

23.1 (15.5)

 

165.3 (128.8)

 
 

76,262

8.6 (8.9)

 

64.5 (74)

 

 s/p CVA

+

2013

18.7 (13.8)

 

135.2 (114.3)

 
 

75,234

8.6 (8.8)

 

63.9 (73.6)

 

 Asthma

+

4714

12.9 (12.2)

 

95.2 (97.7)

 
 

72,533

8.6 (8.8)

 

63.9 (73.7)

 

 COPD

+

1776

20.1 (15.1)

 

143.9 (120.9)

 
 

75,471

8.6 (8.8)

 

63.9 (73.4)

 

 Dementia

+

605

16.8 (13)

 

113.3 (98.1)

 
 

76,642

8.8 (9.1)

 

65.4 (75.4)

 

 Epilepsy

+

918

13.7 (11.3)

 

98.1 (94.7)

 
 

76,329

8.8 (9.1)

 

65.4 (75.4)

 

 Anxiety Disorder

+

2892

16.6 (12.9)

 

121.2 (111)

 
 

74,355

8.5 (8.8)

 

63.6 (73.2)

 

 Drug Abuse

+

496

11.3 (12.7)

 

82 (95.6)

 
 

76,751

8.8 (9.1)

 

65.7 (75.6)

 
  1. AADT Accumulated Annual Duration of Time
  2. IQR Interquartile Range
  3. SES Socioeconomic Status
  4. IHD Ischemic Heart Disease
  5. CHF Chronic Heart Failure
  6. s/p CVA status post Cerebrovascular Accident
  7. COPD Chronic Obstructive Pulmonary Disease